IDEAYA Biosciences Announces Board and Compensation Changes
Ticker: IDYA · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
IDEAYA's board and exec pay got a shake-up effective March 28, 2025.
AI Summary
IDEAYA Biosciences, Inc. announced on March 28, 2025, changes related to its board of directors and executive compensation. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its named executive officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Registrant
- March 28, 2025 (date) — Date of earliest event reported
FAQ
Who departed from IDEAYA Biosciences' board or officer positions?
The filing indicates the departure of certain officers and directors, but does not name them specifically in the provided text.
Were new directors elected to the board?
Yes, the filing states that new directors were elected.
What is the effective date of these reported changes?
The earliest event reported is dated March 28, 2025.
What specific compensatory arrangements were affected?
The filing mentions compensatory arrangements of certain officers were adjusted, but the details are not provided in this excerpt.
What is IDEAYA Biosciences, Inc.'s state of incorporation?
IDEAYA Biosciences, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding IDEAYA Biosciences, Inc. (IDYA).